Concepedia

Mary Becker-Pasha

MB

Statistics

Publications

5

Citations

300

H-Index

5

Active since

2005

Affiliations

Incyte (United States)(Current)

Experimental Station

Mary Becker-Pasha is an author at Incyte (United States) specializing in drug design, enzyme inhibition, and pharmacology.

Publications per year

2005–2009

5

Publications

5

Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics

Andrew P. Combs, Eddy W. Yue, Michael J. Bower et al. · Journal of Medicinal Chemistry · 2005 · 102 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Structural Basis for Inhibition of Protein-tyrosine Phosphatase 1B by Isothiazolidinone Heterocyclic Phosphonate Mimetics

Lucie Gonneville, Milton C. Hillman, Mary Becker-Pasha et al. · Journal of Biological Chemistry · 2006 · 85 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Structural Insights into the Design of Nonpeptidic Isothiazolidinone-containing Inhibitors of Protein-tyrosine Phosphatase 1B

Lucie Gonneville, Milton C. Hillman, Mary Becker-Pasha et al. · Journal of Biological Chemistry · 2006 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

High-Throughput Determination of Mode of Inhibition in Lead Identification and Optimization

Min Wei, Richard Wynn, Gregory Hollis et al. · SLAS DISCOVERY · 2007 · 32 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +15

Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity

Phillip C.C. Liu, Eian Caulder, Jun Li et al. · Clinical Cancer Research · 2009 · 19 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 5